{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:43:56Z","timestamp":1790905436006,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijcard.2024.132951","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T11:45:52Z","timestamp":1735645552000},"page":"132951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Family screening for hypertrophic cardiomyopathy: Initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals"],"prefix":"10.1016","volume":"422","author":[{"given":"Stephan A.C.","family":"Schoonvelde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios M.","family":"Alexandridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura B.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend F.L.","family":"Schinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter-Paul","family":"Zwetsloot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke A.E.","family":"Kammeraad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjon A.","family":"van Slegtenhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.A.","family":"Verhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijcard.2024.132951_bb0005","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132951_bb0010","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2024.132951_bb0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2003.05.009","article-title":"Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults","volume":"116","author":"Zou","year":"2004","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2024.132951_bb0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCULATIONAHA.123.065987","article-title":"Meta-analysis of penetrance and systematic review on transition to disease in genetic hypertrophic cardiomyopathy","volume":"149","author":"Topriceanu","year":"2024","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcard.2024.132951_bb0025","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jacc.2020.06.023","article-title":"Variable penetrance in hypertrophic cardiomyopathy: in search of the Holy Grail","volume":"76","author":"Semsarian","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2024.132951_bb0030","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jacc.2020.06.011","article-title":"Penetrance of hypertrophic cardiomyopathy in sarcomere protein mutation carriers","volume":"76","author":"Lorenzini","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"37","key":"10.1016\/j.ijcard.2024.132951_bb0035","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"issue":"23","key":"10.1016\/j.ijcard.2024.132951_bb0040","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jacc.2024.02.014","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the Management of Hypertrophic Cardiomyopathy: a report of the American Heart Association\/American College of Cardiology Joint Committee on clinical practice guidelines","volume":"83","author":"Ommen","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2024.132951_bb0045","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/ehjci\/jes200","article-title":"Tissue Doppler imaging and prognosis in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy","volume":"14","author":"Kitaoka","year":"2013","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"21","key":"10.1016\/j.ijcard.2024.132951_bb0050","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/eurheartj\/ehp306","article-title":"Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers","volume":"30","author":"Michels","year":"2009","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132951_bb0055","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jacc.2009.01.079","article-title":"Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study","volume":"54","author":"Sorajja","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2024.132951_bb0060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/chd.12280","article-title":"Genotype\u2013phenotype correlations of hypertrophic cardiomyopathy when diagnosed in children, adolescents, and young adults","volume":"10","author":"Loar","year":"2015","journal-title":"Congenit. Heart Dis."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132951_bb0065","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.amjcard.2010.10.022","article-title":"Clinical challenges of genotype positive (+)\u2013phenotype negative (\u2212) family members in hypertrophic cardiomyopathy","volume":"107","author":"Maron","year":"2011","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2024.132951_bb0070","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijcard.2011.07.095","article-title":"Natural history of genotype positive\u2013phenotype negative patients with hypertrophic cardiomyopathy","volume":"152","author":"Gray","year":"2011","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132951_bb0075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.111.090514","article-title":"Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing","volume":"127","author":"Jensen","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2024.132951_bb0080","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003062","article-title":"Associations between female sex, sarcomere variants, and clinical outcomes in hypertrophic cardiomyopathy","volume":"14","author":"Lakdawala","year":"2021","journal-title":"Circ. Genom. Precis. Med."},{"issue":"suppl_1","key":"10.1016\/j.ijcard.2024.132951_bb0085","doi-asserted-by":"crossref","first-page":"P1201","DOI":"10.1093\/eurheartj\/eht308.P1201","article-title":"Follow-up of patients with genotype positive-phenotype negative hypertrophic cardiomyopathy","volume":"34","author":"Vriesendorp","year":"2013","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132951_bb0090","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.117.001896","article-title":"Outcomes of contemporary family screening in hypertrophic cardiomyopathy","volume":"11","author":"van Velzen","year":"2018","journal-title":"Circ. Genom. Precis. Med."},{"issue":"19","key":"10.1016\/j.ijcard.2024.132951_bb0095","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jacc.2024.08.011","article-title":"Family screening in hypertrophic cardiomyopathy: identification of relatives with low yield from systematic follow-up","volume":"84","author":"Silajdzija","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2024.132951_bb0100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"12","key":"10.1016\/j.ijcard.2024.132951_bb0105","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.echo.2012.08.017","article-title":"Measurement of left atrial volume from transthoracic three-dimensional echocardiographic datasets using the biplane Simpson\u2019s technique","volume":"25","author":"Iwataki","year":"2012","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"12","key":"10.1016\/j.ijcard.2024.132951_bb0110","first-page":"1321","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"46","key":"10.1016\/j.ijcard.2024.132951_bb0115","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/eurheartj\/ehx527","article-title":"Women with hypertrophic cardiomyopathy have worse survival","volume":"38","author":"Geske","year":"2017","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132951_bb0120","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2005.04.043","article-title":"Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy","volume":"46","author":"Olivotto","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"21","key":"10.1016\/j.ijcard.2024.132951_bb0125","article-title":"Sex, survival, and cardiomyopathy: differences between men and women with hypertrophic cardiomyopathy","volume":"8","author":"Siontis","year":"2019","journal-title":"Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2024.132951_bb0130","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s10897-018-0218-8","article-title":"Psychosocial impact of a positive gene result for asymptomatic relatives at risk of hypertrophic cardiomyopathy","volume":"27","author":"Bonner","year":"2018","journal-title":"J. Genet. Couns."},{"issue":"30","key":"10.1016\/j.ijcard.2024.132951_bb0135","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur. Heart J."},{"issue":"14","key":"10.1016\/j.ijcard.2024.132951_bb0140","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2024.132951_bb0145","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00392-017-1155-5","article-title":"Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals","volume":"107","author":"Sedaghat-Hamedani","year":"2018","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132951_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-020-01807-4","article-title":"Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy","volume":"20","author":"Velicki","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"issue":"45","key":"10.1016\/j.ijcard.2024.132951_bb0155","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1093\/eurheartj\/ehz396","article-title":"Family screening for hypertrophic cardiomyopathy: is it time to change practice guidelines?","volume":"40","author":"Lafreniere-Roula","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2024.132951_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jpeds.2017.03.033","article-title":"Penetrance of hypertrophic cardiomyopathy in children who are mutation positive","volume":"188","author":"Vermeer","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ijcard.2024.132951_bb0165","doi-asserted-by":"crossref","first-page":"1051564","DOI":"10.3389\/fcvm.2022.1051564","article-title":"Prospects for remodeling the hypertrophic heart with myosin modulators","volume":"9","author":"Sewanan","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2024.132951_bb0170","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCULATIONAHA.120.052359","article-title":"Mavacamten favorably impacts cardiac structure in obstructive hypertrophic cardiomyopathy: EXPLORER-HCM cardiac magnetic resonance substudy analysis","volume":"143","author":"Saberi","year":"2021","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ijcard.2024.132951_bb0175","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.jacc.2021.09.1381","article-title":"Effect of mavacamten on echocardiographic features in symptomatic patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Hegde","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2024.132951_bb0180","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.118.037264","article-title":"Clinical course and significance of hypertrophic cardiomyopathy without left ventricular hypertrophy","volume":"139","author":"Maurizi","year":"2019","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ijcard.2024.132951_bb0185","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1161\/01.CIR.0000019070.70491.6D","article-title":"Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy","volume":"105","author":"Ho","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2024.132951_bb0190","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ahj.2011.05.018","article-title":"Subclinical echocardiographic abnormalities in phenotype-negative carriers of myosin-binding protein C3 gene mutation for hypertrophic cardiomyopathy","volume":"162","author":"De","year":"2011","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132951_bb0195","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.002882","article-title":"Longitudinal changes in left ventricular diastolic function in a general population","volume":"8","author":"Kuznetsova","year":"2015","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"9","key":"10.1016\/j.ijcard.2024.132951_bb0200","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/eurheartj\/ehr092","article-title":"Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy","volume":"32","author":"Christiaans","year":"2011","journal-title":"Eur. Heart J."},{"issue":"24","key":"10.1016\/j.ijcard.2024.132951_bb0205","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2013-303939","article-title":"A systematic review and meta-analysis of genotype\u2013phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations","volume":"99","author":"Lopes","year":"2013","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.ijcard.2024.132951_bb0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41588-020-00764-0","article-title":"Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity","volume":"53","author":"Harper","year":"2021","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.ijcard.2024.132951_bb0215","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jacc.2013.03.062","article-title":"Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy","volume":"62","author":"Olivotto","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"22","key":"10.1016\/j.ijcard.2024.132951_bb0220","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018641","article-title":"Unraveling the genotype-phenotype relationship in hypertrophic cardiomyopathy: obesity-related cardiac defects as a major disease modifier","volume":"9","author":"Nollet","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"10.1016\/j.ijcard.2024.132951_bb0225","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jamacardio.2023.2808","article-title":"Cardiac remodeling in subclinical hypertrophic cardiomyopathy: the VANISH randomized clinical trial","volume":"8","author":"Vissing","year":"2023","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2024.132951_bb0230","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF03091771","article-title":"Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands","volume":"18","author":"Christiaans","year":"2010","journal-title":"Neth. Hear. J."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324015730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324015730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T14:35:11Z","timestamp":1738593311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324015730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":46,"alternative-id":["S0167527324015730"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132951","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.01.24316619","asserted-by":"object"}]},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Family screening for hypertrophic cardiomyopathy: Initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132951","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"132951"}}